1.
Menter A, Sobell J, Silverberg JI, Lebwohl M, Rastogi S, Pillai R, Israel RJ. Long-Term Efficacy of Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: Data from a Pivotal Phase 3 Clinical Trial. J of Skin [Internet]. 2018Feb.23 [cited 2022May22];2(S1):S9. Available from: https://www.jofskin.org/index.php/skin/article/view/253